Primary Care Medicines Optimisation & Pharmacy Procurement Strategic Group

The Primary Care Medicines Use and Procurement Productivity is a strategic London-wide group whose member organisations are clinicians and commissioners from the 5 Sustainability and Transformation Partnerships (STPs) within London, NHS London Procurement Partnership (LPP) Medicines Optimisation Pharmacy & Procurement (MOPP), Specialist Pharmacy Service and NHS London. They are working together to ensure that there is a consistent approach to medicines use and procurement, across London.


The overall aims of the Primary Care Medicines Use and Procurement Productivity Strategic Group are to inform LPP MOPP business planning, promote medicines optimisation agenda which delivers high quality, cost-effective and equitable provision of medicines. The strategic group is also to facilitate consistency of approach, collaboration and sharing of good practice in prescribing and medicines use and procurement within London. It is an opportunity to enable a London focus to the strategic drivers which affect medicines optimisation e.g. emerging integrated care systems, accountable care organisations, 5 year forward view for primary care and mental health, future operating models for procurement, NHSE consultations, Department of Health, Public Health England. The strategic focus is to engage with stakeholders including primary care colleagues and other specialists at London level, leading to mutually agreed decisions and practice where there is benefit to deliver across London.

The benefits to patients and the London organisations of having an effective and integrated approach to QIPP and medicines use and procurement include:

  • Prevent duplication of professional and managerial effort by ensuring joint and collaborative working.
  • Understanding unwarranted variations and priorities in the STP footprints.
  • Enable key stakeholders, working in the NHS locally, to exert an influence on the prioritisation, improvement and development of healthcare delivery.
  • Co-ordinate the safe and cost effective use of medicines across London to improve outcomes for patients.
  • Support medicines optimisation priorities across London with emerging accountable care organisations.
  • Support with development of key performance indicators (KPIs) where relevant.

Objectives of the Medicines Optimisation & Pharmacy Procurement Primary Care Strategic Group:

  1. Agree clinical priorities and KPIs for 2018-20 which supports medicines optimisation agenda. Provide STP and CCG level reports on the agreed priorities where relevant to work streams.
  2.  Identify and disseminate good practice across London and encourage collaboration and sharing where appropriate.
  3.  Engage with secondary care colleagues to understand efficiency plans which can impact primary care and raise awareness of priorities in STP footprints.
  4. Engage with community pharmacists to raise awareness of primary care medicines QIPP priorities.
  5.  To consider impact on primary care and financial cost pressures from development of new drugs/devices, impact of drug shortages and NCSOs.
  6.  To consider clinical initiatives that can be taken forward across the primary and secondary care interface and how best to take these forward.
  7.  Ensure patient safety is incorporated as a specific issue in all decisions and recommendations made by the group, including the safety aspects of the way medicines are used in practice.
  8.  Encourage, support and monitor how the advice, once agreed, is implemented and/or endorsed by relevant organisations, for example, by an implementation and monitoring plan.
  9.  Work in conjunction with the Regional Medicines Optimisation Committee (RMOC) and clinical networks in London where relevant to primary care agenda.
  10.  Primary care savings achievement cross STP footprints- local challenges and opportunities.
  11.  Respond to medicines optimisation opportunities and challenges in primary care within the changing NHS landscape.
  12.  To provide strategic oversight to task & finish groups and other associated MOPP working groups including work plans and products that will be useful for stakeholders.
  13.  To consider how national drivers may inform the LPP MOPP work streams to support London e.g. NHS Right Care, NHS England initiatives, consultations, NICE.
  14.  To respond to any strategic issues and challenges highlighted by the LPP Steering Board (where relevant to MOPP) and Pan-London Chief Pharmacists network.

 For further information please contact